Partnership

We create possibilities for patients by simplifying complex treatments.

We are a dedicated bridge between innovative global healthcare solutions and the unique Nordic landscape. We specialize in delivering complex pharma and medtech treatments - primarily focused on home based treatments like; inhalation, intravenous or subcutaneous infused treatments of mainly chronic diseases across Sweden, Finland, Denmark, Norway, and Iceland.

We believe that successful management of chronic diseases requires an integrated approach to simplify the often complex treatments. Our model combines critical pillars to ensure therapy success:

1. Innovative Drugs & Devices: Expert distribution of high-value pharmaceuticals and specialized medtech.
2. Professional Support: Important differentiator to ensure success of the treatment. Potential solutions include dedicated technical and nursing support teams available across all five Nordic countries.
3. Personalized Services: Patient support programs, trainings and innovative services that ensure safe, effective care in the home environment with a good adherence.

We currently have a portfolio of medtech and pharma solutions covering core therapeutic needs, including Diabetes (Type 1 & Type 2), Parkinson's, Immunology, Infection, Pain and Cardiology/Pulmonary care.

We are looking for new partners within our current therapeutic areas as well as areas where synergies can be found.

Why partner with us?

Your Gateway to the Nordic market

The Strategy & Business Development functions at NIC manages, in close collaboration with business units, the entire lifecycle of a partnership.

Our Capabilities

With an established geographic footprint across Sweden, Denmark, Norway, Finland, and Iceland, our organization provides a comprehensive, Nordic-wide structure backed by over 130 dedicated professionals. We combine deep regional insights with local presence to ensure high-level engagement and seamless market entry for our partners.

Our core competencies span the entire product lifecycle, from Regulatory and Quality, where we maintain in-house expertise, a full QMS, and licenses to sell drugs and medical devices - to Market Access and Tender Management. We are experts at navigating complex public tenders and negotiating pricing and reimbursement with local healthcare authorities, effectively balancing clinical outcomes with economic requirements.

Commercially, we drive growth by localizing global marketing strategies through expert translation and regional campaign execution. Our extensive HCP and hospital networks are supported by robust logistics solutions and local database segmentations in each country, ensuring that both pharmaceutical and medical device needs are met with precision and compliance.

What we are looking for

We are actively seeking long-term distribution partnerships, in-licensing opportunities, and other collaborations with companies that offer solutions for chronic conditions that target unmet needs.

Therapeutic areas of interest

We manage both orphan drugs and common conditions within these core specialties:

• Neurology &  Diseases in the Nervous system: Movement disorders and other nervous degenerative diseases (e.g., Parkinson’s), ALS, Huntington…
• Diabetes & Endocrinology: Solutions for Pre-Diabetes, Type 1, and Type 2.
• Immunology: Specialized treatments for autoimmune and immune-related conditions.
• Respiratory & Pulmonology: Including advanced inhalation therapies.
• Cardiovascular & Metabolic: Treatments for PAH, nutritional, and metabolic diseases.
• At-Home Care: Technologies that enable the shift from hospital to home-based treatment including pain and palliation. 
• Others: Therapeutic areas that have synergies with current structure are of interest.

Part of the Air Liquide Healthcare 

NordicInfu Care is an agile partner of Air Liquide Healthcare, a major world player in healthcare, an expert in chronic diseases follow up at home and new places of care, and supplier of services and medical gases solution for hospitals.

• Global strength: Air Liquide Healthcare generates ~€4bn in revenue supporting ~2.1m patients worldwide leaving with chronic diseases, serving 20,000 hospitals and 140,000 healthcare professionals
• Home Healthcare Expertise: A major world player in chronic disease follow-up and hospital gas supply.
• Stability: Our ownership ensures long-term financial stability and global-standard compliance.